<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1994-06-01" modified="2018-01-31" version="182">
<accession>Q01650</accession>
<accession>Q8IV97</accession>
<accession>Q9UBN8</accession>
<accession>Q9UP15</accession>
<accession>Q9UQC0</accession>
<name>LAT1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Large neutral amino acids transporter small subunit 1</fullName>
</recommendedName>
<alternativeName>
<fullName>4F2 light chain</fullName>
<shortName>4F2 LC</shortName>
<shortName>4F2LC</shortName>
</alternativeName>
<alternativeName>
<fullName>CD98 light chain</fullName>
</alternativeName>
<alternativeName>
<fullName>Integral membrane protein E16</fullName>
</alternativeName>
<alternativeName>
<fullName>L-type amino acid transporter 1</fullName>
<shortName>hLAT1</shortName>
</alternativeName>
<alternativeName>
<fullName>Solute carrier family 7 member 5</fullName>
</alternativeName>
<alternativeName>
<fullName>y+ system cationic amino acid transporter</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">SLC7A5</name>
<name type="synonym">CD98LC</name>
<name type="synonym">LAT1</name>
<name type="synonym">MPE16</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Nature" volume="395" first="288" last="291">
<title>Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.</title>
<authorList>
<person name="Mastroberardino L."/>
<person name="Spindler B."/>
<person name="Pfeiffer R."/>
<person name="Skelly P.J."/>
<person name="Loffing J."/>
<person name="Shoemaker C.B."/>
<person name="Verrey F."/>
</authorList>
<dbReference type="PubMed" id="9751058"/>
<dbReference type="DOI" id="10.1038/26246"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>VARIANT LYS-230</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="Biochem. Biophys. Res. Commun." volume="255" first="283" last="288">
<title>Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function.</title>
<authorList>
<person name="Prasad P.D."/>
<person name="Wang H."/>
<person name="Huang W."/>
<person name="Kekuda R."/>
<person name="Rajan D.P."/>
<person name="Leibach F.H."/>
<person name="Ganapathy V."/>
</authorList>
<dbReference type="PubMed" id="10049700"/>
<dbReference type="DOI" id="10.1006/bbrc.1999.0206"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1999" name="J. Immunol." volume="162" first="2462" last="2466">
<title>Primary structure of the light chain of fusion regulatory protein-1/CD98/4F2 predicts a protein with multiple transmembrane domains that is almost identical to the amino acid transporter E16.</title>
<authorList>
<person name="Tsurudome M."/>
<person name="Ito M."/>
<person name="Takebayashi S."/>
<person name="Okumura K."/>
<person name="Nishio M."/>
<person name="Kawano M."/>
<person name="Kusagawa S."/>
<person name="Komada H."/>
<person name="Ito Y."/>
</authorList>
<dbReference type="PubMed" id="10072483"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2001" name="Biochim. Biophys. Acta" volume="1514" first="291" last="302">
<title>Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.</title>
<authorList>
<person name="Yanagida O."/>
<person name="Kanai Y."/>
<person name="Chairoungdua A."/>
<person name="Kim D.K."/>
<person name="Segawa H."/>
<person name="Nii T."/>
<person name="Cha S.H."/>
<person name="Matsuo H."/>
<person name="Fukushima J."/>
<person name="Fukasawa Y."/>
<person name="Tani Y."/>
<person name="Taketani Y."/>
<person name="Uchino H."/>
<person name="Kim J.Y."/>
<person name="Inatomi J."/>
<person name="Okayasu I."/>
<person name="Miyamoto K."/>
<person name="Takeda E."/>
<person name="Goya T."/>
<person name="Endou H."/>
</authorList>
<dbReference type="PubMed" id="11557028"/>
<dbReference type="DOI" id="10.1016/S0005-2736(01)00384-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Ovary</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="1998-09" db="EMBL/GenBank/DDBJ databases">
<title>Human 4F2 light chain: amino acid transporter.</title>
<authorList>
<person name="Minato N."/>
<person name="Iwai K."/>
<person name="Takizawa C."/>
<person name="Nakamura E."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT VAL-223</scope>
<source>
<tissue>Liver</tissue>
<tissue>Lymph</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="11267" last="11273">
<title>A novel transiently expressed, integral membrane protein linked to cell activation. Molecular cloning via the rapid degradation signal AUUUA.</title>
<authorList>
<person name="Gaugitsch H.W."/>
<person name="Prieschl E.E."/>
<person name="Kalthoff F."/>
<person name="Huber N.E."/>
<person name="Baumruker T."/>
</authorList>
<dbReference type="PubMed" id="1597461"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 181-507</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
<source>
<tissue>Peripheral blood lymphocyte</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="19738" last="19744">
<title>Identification of a membrane protein, LAT-2, that co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.</title>
<authorList>
<person name="Pineda M."/>
<person name="Fernandez E."/>
<person name="Torrents D."/>
<person name="Estevez R."/>
<person name="Lopez C."/>
<person name="Camps M."/>
<person name="Lloberas J."/>
<person name="Zorzano A."/>
<person name="Palacin M."/>
</authorList>
<dbReference type="PubMed" id="10391915"/>
<dbReference type="DOI" id="10.1074/jbc.274.28.19738"/>
</citation>
<scope>FUNCTION</scope>
<scope>INHIBITION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="34948" last="34954">
<title>LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.</title>
<authorList>
<person name="Rossier G."/>
<person name="Meier C."/>
<person name="Bauch C."/>
<person name="Summa V."/>
<person name="Sordat B."/>
<person name="Verrey F."/>
<person name="Kuehn L.C."/>
</authorList>
<dbReference type="PubMed" id="10574970"/>
<dbReference type="DOI" id="10.1074/jbc.274.49.34948"/>
</citation>
<scope>FUNCTION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2001" name="Biochem. J." volume="355" first="725" last="731">
<title>Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains.</title>
<authorList>
<person name="Broeer A."/>
<person name="Friedrich B."/>
<person name="Wagner C.A."/>
<person name="Fillon S."/>
<person name="Ganapathy V."/>
<person name="Lang F."/>
<person name="Broeer S."/>
</authorList>
<dbReference type="PubMed" id="11311135"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="Biochem. J." volume="356" first="719" last="725">
<title>Role of the System L permease LAT1 in amino acid and iodothyronine transport in placenta.</title>
<authorList>
<person name="Ritchie J.W.A."/>
<person name="Taylor P.M."/>
</authorList>
<dbReference type="PubMed" id="11389679"/>
<dbReference type="DOI" id="10.1042/0264-6021:3560719"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INHIBITION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="Endocrinology" volume="142" first="4339" last="4348">
<title>Thyroid hormone transport by the heterodimeric human system L amino acid transporter.</title>
<authorList>
<person name="Friesema E.C.H."/>
<person name="Docter R."/>
<person name="Moerings E.P.C.M."/>
<person name="Verrey F."/>
<person name="Krenning E.P."/>
<person name="Hennemann G."/>
<person name="Visser T.J."/>
</authorList>
<dbReference type="PubMed" id="11564694"/>
<dbReference type="DOI" id="10.1210/endo.142.10.8418"/>
</citation>
<scope>FUNCTION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>SUBUNIT</scope>
<scope>INHIBITION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="Am. J. Physiol." volume="282" first="C196" last="C204">
<title>Expression and regulation of 4F2hc and hLAT1 in human trophoblasts.</title>
<authorList>
<person name="Okamoto Y."/>
<person name="Sakata M."/>
<person name="Ogura K."/>
<person name="Yamamoto T."/>
<person name="Yamaguchi M."/>
<person name="Tasaka K."/>
<person name="Kurachi H."/>
<person name="Tsurudome M."/>
<person name="Murata Y."/>
</authorList>
<dbReference type="PubMed" id="11742812"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2002" name="Biochem. J." volume="367" first="239" last="246">
<title>Transport of a neurotoxicant by molecular mimicry: the methylmercury-L-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2.</title>
<authorList>
<person name="Simmons-Willis T.A."/>
<person name="Koh A.S."/>
<person name="Clarkson T.W."/>
<person name="Ballatori N."/>
</authorList>
<dbReference type="PubMed" id="12117417"/>
<dbReference type="DOI" id="10.1042/BJ20020841"/>
</citation>
<scope>FUNCTION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>INHIBITION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2002" name="Biochim. Biophys. Acta" volume="1565" first="112" last="121">
<title>Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.</title>
<authorList>
<person name="Kim D.K."/>
<person name="Kanai Y."/>
<person name="Choi H.W."/>
<person name="Tangtrongsup S."/>
<person name="Chairoungdua A."/>
<person name="Babu E."/>
<person name="Tachampa K."/>
<person name="Anzai N."/>
<person name="Iribe Y."/>
<person name="Endou H."/>
</authorList>
<dbReference type="PubMed" id="12225859"/>
<dbReference type="DOI" id="10.1016/S0005-2736(02)00516-3"/>
</citation>
<scope>FUNCTION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INHIBITION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="Invest. Ophthalmol. Vis. Sci." volume="44" first="2919" last="2927">
<title>Identification and functional characterization of a Na+-independent large neutral amino acid transporter, LAT1, in human and rabbit cornea.</title>
<authorList>
<person name="Jain-Vakkalagadda B."/>
<person name="Dey S."/>
<person name="Pal D."/>
<person name="Mitra A.K."/>
</authorList>
<dbReference type="PubMed" id="12824232"/>
<dbReference type="DOI" id="10.1167/iovs.02-0907"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="Amino Acids" volume="29" first="229" last="233">
<title>Expression of LAT1 and LAT2 amino acid transporters in human and rat intestinal epithelial cells.</title>
<authorList>
<person name="Fraga S."/>
<person name="Pinho M.J."/>
<person name="Soares-da-Silva P."/>
</authorList>
<dbReference type="PubMed" id="16027961"/>
<dbReference type="DOI" id="10.1007/s00726-005-0221-x"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="20102" last="20110">
<title>Identification of stereoselective transporters for S-nitroso-L-cysteine: role of LAT1 and LAT2 in biological activity of S-nitrosothiols.</title>
<authorList>
<person name="Li S."/>
<person name="Whorton A.R."/>
</authorList>
<dbReference type="PubMed" id="15769744"/>
<dbReference type="DOI" id="10.1074/jbc.M413164200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INHIBITION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Int. J. Cancer" volume="119" first="484" last="492">
<title>L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors.</title>
<authorList>
<person name="Nawashiro H."/>
<person name="Otani N."/>
<person name="Shinomiya N."/>
<person name="Fukui S."/>
<person name="Ooigawa H."/>
<person name="Shima K."/>
<person name="Matsuo H."/>
<person name="Kanai Y."/>
<person name="Endou H."/>
</authorList>
<dbReference type="PubMed" id="16496379"/>
<dbReference type="DOI" id="10.1002/ijc.21866"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Neurosci. Lett." volume="434" first="56" last="60">
<title>Functional characterization of tyrosine transport in fibroblast cells from healthy controls.</title>
<authorList>
<person name="Vumma R."/>
<person name="Wiesel F.A."/>
<person name="Flyckt L."/>
<person name="Bjerkenstedt L."/>
<person name="Venizelos N."/>
</authorList>
<dbReference type="PubMed" id="18262359"/>
<dbReference type="DOI" id="10.1016/j.neulet.2008.01.028"/>
</citation>
<scope>FUNCTION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>INHIBITION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31 AND THR-45</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31; SER-35 AND THR-45</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2015" name="Nat. Commun." volume="6" first="7250" last="7250">
<title>LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation.</title>
<authorList>
<person name="Milkereit R."/>
<person name="Persaud A."/>
<person name="Vanoaica L."/>
<person name="Guetg A."/>
<person name="Verrey F."/>
<person name="Rotin D."/>
</authorList>
<dbReference type="PubMed" id="25998567"/>
<dbReference type="DOI" id="10.1038/ncomms8250"/>
</citation>
<scope>INTERACTION WITH LAPTM4B</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<comment type="function">
<text evidence="7 9 10 11 12 13 14 15 16 17 20 23 24 25 26">Sodium-independent, high-affinity transport of large neutral amino acids such as phenylalanine, tyrosine, leucine, arginine and tryptophan, when associated with SLC3A2/4F2hc. Involved in cellular amino acid uptake. Acts as an amino acid exchanger. Involved in the transport of L-DOPA across the blood-brain barrier, and that of thyroid hormones triiodothyronine (T3) and thyroxine (T4) across the cell membrane in tissues such as placenta. Plays a role in neuronal cell proliferation (neurogenesis) in brain. Involved in the uptake of methylmercury (MeHg) when administered as the L-cysteine or D,L-homocysteine complexes, and hence plays a role in metal ion homeostasis and toxicity. Involved in the cellular activity of small molecular weight nitrosothiols, via the stereoselective transport of L-nitrosocysteine (L-CNSO) across the transmembrane. May play an important role in high-grade gliomas. Mediates blood-to-retina L-leucine transport across the inner blood-retinal barrier which in turn may play a key role in maintaining large neutral amino acids as well as neurotransmitters in the neural retina. Acts as the major transporter of tyrosine in fibroblasts. When associated with LAPTM4B, recruits SLC3A2 and SLC7A5 to lysosomes to promote leucine uptake into these organelles and is required for mTORC1 activation (PubMed:25998567).</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="10 14 16 17 24">7.9 uM for T4 (in the presence of choline chloride)</KM>
<KM evidence="10 14 16 17 24">0.8 uM for T3 (in the presence of choline chloride)</KM>
<KM evidence="10 14 16 17 24">12.5 uM for reverse triiodothyronine (rT3) (in the presence of choline chloride)</KM>
<KM evidence="10 14 16 17 24">7.9 uM for 3,3'-diiodothyronine (in the presence of choline chloride)</KM>
<KM evidence="10 14 16 17 24">46 uM for leucine (in the presence of choline chloride)</KM>
<KM evidence="10 14 16 17 24">19 uM for tryptophan (in the presence of choline chloride)</KM>
<KM evidence="10 14 16 17 24">32 uM for L-leucine</KM>
<KM evidence="10 14 16 17 24">10 mM for L-alanine</KM>
<KM evidence="10 14 16 17 24">2.2 mM for L-glutamine</KM>
<KM evidence="10 14 16 17 24">35 uM for L-histidine</KM>
<KM evidence="10 14 16 17 24">740 uM for L-phenylalanine</KM>
<KM evidence="10 14 16 17 24">98 uM for MeHg-L-cysteine</KM>
<KM evidence="10 14 16 17 24">99 uM for methionine</KM>
<KM evidence="10 14 16 17 24">55.2 uM for phenylalanine (in T24 human bladder carcinoma cells)</KM>
<KM evidence="10 14 16 17 24">60.4 uM for tyrosine (in T24 human bladder carcinoma cells)</KM>
<KM evidence="10 14 16 17 24">16.4 uM for tyrosine (in human fibroblasts)</KM>
<KM evidence="10 14 16 17 24">138 uM for Dopa (in T24 human bladder carcinoma cells)</KM>
<KM evidence="10 14 16 17 24">96.5 uM for 3-O-methyldopa (in T24 human bladder carcinoma cells)</KM>
<KM evidence="10 14 16 17 24">153 uM for alpha-methyltyrosine (in T24 human bladder carcinoma cells)</KM>
<KM evidence="10 14 16 17 24">216 uM for alpha-methyldopa (in T24 human bladder carcinoma cells)</KM>
<KM evidence="10 14 16 17 24">191 uM for gabapentin (in T24 human bladder carcinoma cells)</KM>
<KM evidence="10 14 16 17 24">7.3 uM for triiodothyronine (in T24 human bladder carcinoma cells)</KM>
<KM evidence="10 14 16 17 24">162 uM for thyroxine (in T24 human bladder carcinoma cells)</KM>
<KM evidence="10 14 16 17 24">75.3 uM for melphanan (in T24 human bladder carcinoma cells)</KM>
<KM evidence="10 14 16 17 24">156 uM for BCH (in T24 human bladder carcinoma cells)</KM>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="7 11 12 13 14 17 20 25 26">Disulfide-linked heterodimer with the amino acid transport protein SLC3A2/4F2hc (PubMed:10049700, PubMed:11311135, PubMed:11389679, PubMed:11557028, PubMed:11564694, PubMed:12225859, PubMed:15769744, PubMed:9751058). Interacts with LAPTM4B; recruits SLC3A2 and SLC7A5 to lysosomes to promote leucine uptake into these organelles and is required for mTORC1 activation (PubMed:25998567).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
<location>cytosol</location>
</subcellularLocation>
<subcellularLocation>
<location>Apical cell membrane</location>
<topology>Multi-pass membrane protein</topology>
</subcellularLocation>
<text evidence="5">Located to the plasma membrane by SLC3A2/4F2hc. Localized to the apical membrane of placental syncytiophoblastic cells. Expressed in both luminal and abluminal membranes of brain capillary endothelial cells (By similarity).</text>
</comment>
<comment type="tissue specificity">
<text evidence="7 8 12 13 15 18 21 22 23">Expressed abundantly in adult lung, liver, brain, skeletal muscle, placenta, bone marrow, testis, resting lymphocytes and monocytes, and in fetal liver. Weaker expression in thymus, cornea, retina, peripheral leukocytes, spleen, kidney, colon and lymph node. During gestation, expression in the placenta was significantly stronger at full-term than at the mid-trimester stage. Also expressed in all human tumor cell lines tested and in the astrocytic process of primary astrocytic gliomas. Expressed in retinal endothelial cells and in the intestinal epithelial cell line Caco-2.</text>
</comment>
<comment type="induction">
<text evidence="15 21">Expression induced in quiescent peripheral blood lymphocytes after treatment with phorbol myristate acetate (PMA) and phytohemagglutinin (PHA). Expression and the uptake of leucine is stimulated in mononuclear, cytotrophoblast-like choriocarcinoma cells by combined treatment with PMA and calcium ionophore.</text>
</comment>
<comment type="miscellaneous">
<text>The uptake of leucine, tyrosine and tryptophan is inhibited by the different iodothyronines, in particular T3. Leucine transport is also inhibited by small zwitterionic amino acids (i.e. glycine, alanine, serine, threonine and cysteine) and by glutamine and asparagine. The uptake of T3 is almost completely blocked by coincubation with leucine, tryptophan, tyrosine, and phenylalanine, or 2-amino-bicyclo-(2,2,1)-heptane-2-carboxylate (BCH). Methionine uptake was inhibited by the L-system substrates L-leucine, BCH, L-cysteine and by the MeHg-L-cysteine complex and structurally related S-ethyl-L-cysteine. MeHg-L-cysteine uptake is inhibited by L-methionine, L-leucine, BCH and S-ethyl-L-cysteine. L-leucine uptake was inhibited by L-CNSO. Tyrosine uptake in fibroblasts was inhibited by D-methionine, and methyl-aminoisobutyric acid (MeAIB).</text>
</comment>
<comment type="similarity">
<text evidence="27">Belongs to the amino acid-polyamine-organocation (APC) superfamily. L-type amino acid transporter (LAT) (TC 2.A.3.8) family.</text>
</comment>
<dbReference type="EMBL" id="AF077866">
<property type="protein sequence ID" value="AAC61479.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF104032">
<property type="protein sequence ID" value="AAD20464.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB018542">
<property type="protein sequence ID" value="BAA33851.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB018009">
<property type="protein sequence ID" value="BAA84648.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB017908">
<property type="protein sequence ID" value="BAA75746.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC039692">
<property type="protein sequence ID" value="AAH39692.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC042600">
<property type="protein sequence ID" value="AAH42600.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M80244">
<property type="protein sequence ID" value="AAA35780.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10964.1"/>
<dbReference type="PIR" id="JG0165">
<property type="entry name" value="JG0165"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003477.4">
<property type="nucleotide sequence ID" value="NM_003486.6"/>
</dbReference>
<dbReference type="UniGene" id="Hs.513797"/>
<dbReference type="ProteinModelPortal" id="Q01650"/>
<dbReference type="BioGrid" id="113801">
<property type="interactions" value="16"/>
</dbReference>
<dbReference type="IntAct" id="Q01650">
<property type="interactions" value="20"/>
</dbReference>
<dbReference type="MINT" id="MINT-5000558"/>
<dbReference type="STRING" id="9606.ENSP00000261622"/>
<dbReference type="ChEMBL" id="CHEMBL4459"/>
<dbReference type="DrugBank" id="DB01746">
<property type="generic name" value="D-Leucine"/>
</dbReference>
<dbReference type="DrugBank" id="DB02556">
<property type="generic name" value="D-Phenylalanine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00509">
<property type="generic name" value="Dextrothyroxine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01235">
<property type="generic name" value="Levodopa"/>
</dbReference>
<dbReference type="DrugBank" id="DB00451">
<property type="generic name" value="Levothyroxine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00279">
<property type="generic name" value="Liothyronine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01042">
<property type="generic name" value="Melphalan"/>
</dbReference>
<dbReference type="DrugBank" id="DB02750">
<property type="generic name" value="S-(Methylmercury)-L-Cysteine"/>
</dbReference>
<dbReference type="TCDB" id="2.A.3.8.25">
<property type="family name" value="the amino acid-polyamine-organocation (apc) family"/>
</dbReference>
<dbReference type="iPTMnet" id="Q01650"/>
<dbReference type="PhosphoSitePlus" id="Q01650"/>
<dbReference type="SwissPalm" id="Q01650"/>
<dbReference type="BioMuta" id="SLC7A5"/>
<dbReference type="DMDM" id="12643412"/>
<dbReference type="EPD" id="Q01650"/>
<dbReference type="MaxQB" id="Q01650"/>
<dbReference type="PaxDb" id="Q01650"/>
<dbReference type="PeptideAtlas" id="Q01650"/>
<dbReference type="PRIDE" id="Q01650"/>
<dbReference type="TopDownProteomics" id="Q01650"/>
<dbReference type="DNASU" id="8140"/>
<dbReference type="Ensembl" id="ENST00000261622">
<property type="protein sequence ID" value="ENSP00000261622"/>
<property type="gene ID" value="ENSG00000103257"/>
</dbReference>
<dbReference type="GeneID" id="8140"/>
<dbReference type="KEGG" id="hsa:8140"/>
<dbReference type="UCSC" id="uc002fkm.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8140"/>
<dbReference type="DisGeNET" id="8140"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000103257.8"/>
<dbReference type="GeneCards" id="SLC7A5"/>
<dbReference type="HGNC" id="HGNC:11063">
<property type="gene designation" value="SLC7A5"/>
</dbReference>
<dbReference type="HPA" id="HPA052673"/>
<dbReference type="HPA" id="HPA056077"/>
<dbReference type="MIM" id="600182">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q01650"/>
<dbReference type="OpenTargets" id="ENSG00000103257"/>
<dbReference type="PharmGKB" id="PA35923"/>
<dbReference type="eggNOG" id="KOG1287">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0531">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119037"/>
<dbReference type="HOGENOM" id="HOG000098892"/>
<dbReference type="HOVERGEN" id="HBG000476"/>
<dbReference type="InParanoid" id="Q01650"/>
<dbReference type="KO" id="K13780"/>
<dbReference type="OMA" id="FTCIMTL"/>
<dbReference type="OrthoDB" id="EOG091G07EM"/>
<dbReference type="PhylomeDB" id="Q01650"/>
<dbReference type="TreeFam" id="TF313355"/>
<dbReference type="BioCyc" id="MetaCyc:ENSG00000103257-MONOMER"/>
<dbReference type="Reactome" id="R-HSA-210991">
<property type="pathway name" value="Basigin interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-352230">
<property type="pathway name" value="Amino acid transport across the plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-71240">
<property type="pathway name" value="Tryptophan catabolism"/>
</dbReference>
<dbReference type="SABIO-RK" id="Q01650"/>
<dbReference type="ChiTaRS" id="SLC7A5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="SLC7A5"/>
<dbReference type="GenomeRNAi" id="8140"/>
<dbReference type="PRO" id="PR:Q01650"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000103257"/>
<dbReference type="CleanEx" id="HS_SLC7A5"/>
<dbReference type="ExpressionAtlas" id="Q01650">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q01650">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015171">
<property type="term" value="F:amino acid transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015297">
<property type="term" value="F:antiporter activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0015179">
<property type="term" value="F:L-amino acid transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0015175">
<property type="term" value="F:neutral amino acid transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042605">
<property type="term" value="F:peptide antigen binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006520">
<property type="term" value="P:cellular amino acid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:1902475">
<property type="term" value="P:L-alpha-amino acid transmembrane transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050900">
<property type="term" value="P:leukocyte migration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007399">
<property type="term" value="P:nervous system development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0015804">
<property type="term" value="P:neutral amino acid transport"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006810">
<property type="term" value="P:transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="InterPro" id="IPR002293">
<property type="entry name" value="AA/rel_permease1"/>
</dbReference>
<dbReference type="InterPro" id="IPR004760">
<property type="entry name" value="L_AA_transporter"/>
</dbReference>
<dbReference type="Pfam" id="PF13520">
<property type="entry name" value="AA_permease_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF006060">
<property type="entry name" value="AA_transporter"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR00911">
<property type="entry name" value="2A0308"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0029">Amino-acid transport</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0524">Neurogenesis</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Large neutral amino acids transporter small subunit 1" id="PRO_0000054270">
<location>
<begin position="1"/>
<end position="507"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="50"/>
<end position="70"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="84"/>
<end position="104"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="120"/>
<end position="140"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="146"/>
<end position="166"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="170"/>
<end position="190"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="199"/>
<end position="219"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="243"/>
<end position="263"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="274"/>
<end position="294"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="319"/>
<end position="339"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="396"/>
<end position="416"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="431"/>
<end position="451"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="458"/>
<end position="478"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 2 3 4">
<location>
<position position="31"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="35"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="2 4">
<location>
<position position="45"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="49"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="230"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="340"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)">
<location>
<position position="19"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)">
<location>
<position position="30"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17853937." id="VAR_070119" evidence="19">
<original>D</original>
<variation>V</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1060250." id="VAR_048157" evidence="26">
<original>N</original>
<variation>K</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAA75746." ref="5" evidence="27">
<original>A</original>
<variation>V</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAA75746." ref="5" evidence="27">
<original>AKS</original>
<variation>SKR</variation>
<location>
<begin position="29"/>
<end position="31"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAA75746." ref="5" evidence="27">
<original>S</original>
<variation>A</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAA75746." ref="5" evidence="27">
<original>T</original>
<variation>A</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAA75746." ref="5" evidence="27">
<original>V</original>
<variation>M</variation>
<location>
<position position="88"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAA75746." ref="5" evidence="27">
<original>T</original>
<variation>A</variation>
<location>
<position position="154"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250"/>
<evidence key="6" type="ECO:0000255"/>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10049700"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10072483"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10391915"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10574970"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11311135"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11389679"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11557028"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11564694"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11742812"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12117417"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12225859"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12824232"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15769744"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1597461"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16027961"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16496379"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18262359"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25998567"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9751058"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000305"/>
<sequence length="507" mass="55010" checksum="767F3C60B62C0F02" modified="2001-01-24" version="2">
MAGAGPKRRALAAPAAEEKEEAREKMLAAKSADGSAPAGEGEGVTLQRNITLLNGVAIIV
GTIIGSGIFVTPTGVLKEAGSPGLALVVWAACGVFSIVGALCYAELGTTISKSGGDYAYM
LEVYGSLPAFLKLWIELLIIRPSSQYIVALVFATYLLKPLFPTCPVPEEAAKLVACLCVL
LLTAVNCYSVKAATRVQDAFAAAKLLALALIILLGFVQIGKGDVSNLDPNFSFEGTKLDV
GNIVLALYSGLFAYGGWNYLNFVTEEMINPYRNLPLAIIISLPIVTLVYVLTNLAYFTTL
STEQMLSSEAVAVDFGNYHLGVMSWIIPVFVGLSCFGSVNGSLFTSSRLFFVGSREGHLP
SILSMIHPQLLTPVPSLVFTCVMTLLYAFSKDIFSVINFFSFFNWLCVALAIIGMIWLRH
RKPELERPIKVNLALPVFFILACLFLIAVSFWKTPVECGIGFTIILSGLPVYFFGVWWKN
KPKWLLQGIFSTTVLCQKLMQVVPQET
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>